Jotin Marango
Director of Finance/CFO presso IKENA ONCOLOGY, INC.
Patrimonio netto: - $ in data 31/03/2024
Profilo
Jotin Marango is currently the Chief Financial Officer at Ikena Oncology, Inc. Prior to this, he was the Chief Financial, Accounting & Business Officer at Aptose Biosciences, Inc. from 2019 to 2022.
He was also a Managing Director at ROTH Capital Partners LLC from 2017 to 2019.
Before that, he worked as the Chief Operating Officer at Samuel Waxman Cancer Research Foundation from 2012 to 2015 and as Equity Research at H.
C.
Wainwright & Co. LLC from 2015 to 2017.
Dr. Marango received his undergraduate degree from Harvard University in 2001 and his doctorate from Icahn School of Medicine at Mount Sinai in 2009.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
IKENA ONCOLOGY, INC.
-.--% | 01/02/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Jotin Marango
| Società | Posizione | Inizio |
|---|---|---|
| IKENA ONCOLOGY, INC. | Director of Finance/CFO | 25/04/2022 |
Precedenti posizioni note di Jotin Marango
| Società | Posizione | Fine |
|---|---|---|
| APTOSE BIOSCIENCES INC. | Director of Finance/CFO | 07/04/2022 |
ROTH Capital Partners LLC
 ROTH Capital Partners LLC Investment Banks/BrokersFinance ROTH Capital Partners LLC is a broker/dealer headquartered in Newport Beach, California. The firm was founded in 2001 and is a subsidiary of CR Financial Holdings, Inc. They offer institutional sales and trading services. Their broad institutional coverage includes investors in North America, Canada, UK, Europe and other international territories. | Analyst-Equity | 01/05/2019 |
H. C. Wainwright & Co. LLC
 H. C. Wainwright & Co. LLC Investment Banks/BrokersFinance H. C. Wainwright & Co. LLC (H. C. Wainwright) is a full-service broker/dealer headquartered in New York City. The firm was founded in 1868 and is a subsidiary of HCWHC, Inc. H. C. Wainwright delivers industry insights and real-time execution to both public and private small and middle-sized global emerging market companies. With a focus on identifying buyers and sellers in illiquid and difficult to trade equities, the firm specializes in block trading and providing liquidity in these securities with as little market impact as possible. | Analyst-Equity | 01/08/2017 |
Samuel Waxman Cancer Research Foundation
 Samuel Waxman Cancer Research Foundation Miscellaneous Commercial ServicesCommercial Services Samuel Waxman Cancer Research Foundation provides medical research and development services to reduce cancer decease. The company was founded by Samuel Waxman in 1976 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/01/2015 |
Formazione di Jotin Marango
| Harvard University | Undergraduate Degree |
| Icahn School of Medicine at Mount Sinai | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| APTOSE BIOSCIENCES INC. | Health Technology |
| IKENA ONCOLOGY, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
ROTH Capital Partners LLC
ROTH Capital Partners LLC Investment Banks/BrokersFinance ROTH Capital Partners LLC is a broker/dealer headquartered in Newport Beach, California. The firm was founded in 2001 and is a subsidiary of CR Financial Holdings, Inc. They offer institutional sales and trading services. Their broad institutional coverage includes investors in North America, Canada, UK, Europe and other international territories. | Finance |
H. C. Wainwright & Co. LLC
H. C. Wainwright & Co. LLC Investment Banks/BrokersFinance H. C. Wainwright & Co. LLC (H. C. Wainwright) is a full-service broker/dealer headquartered in New York City. The firm was founded in 1868 and is a subsidiary of HCWHC, Inc. H. C. Wainwright delivers industry insights and real-time execution to both public and private small and middle-sized global emerging market companies. With a focus on identifying buyers and sellers in illiquid and difficult to trade equities, the firm specializes in block trading and providing liquidity in these securities with as little market impact as possible. | Finance |
Samuel Waxman Cancer Research Foundation
Samuel Waxman Cancer Research Foundation Miscellaneous Commercial ServicesCommercial Services Samuel Waxman Cancer Research Foundation provides medical research and development services to reduce cancer decease. The company was founded by Samuel Waxman in 1976 and is headquartered in New York, NY. | Commercial Services |
- Borsa valori
- Insiders
- Jotin Marango
